The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Sphingosine kinase 1 is up‐regulated in colon carcinogenesis
Abstract
Sphingosine kinase 1 (SK1) phosphorylates sphingosine to form sphingosine 1‐phosphate (S1P), which has the ability to promote cell proliferation and survival and stimulate angiogenesis. The SK1/S1P pathway also plays a critical role in regulation of cyclooxygenase‐2 (COX‐2), a well‐established pathogenic factor in colon carcinogenesis. Therefore, we examined the expression of SK1 and COX‐2 in rat colon tumors induced by azoxymethane (AOM) and the relationship of these two proteins in normal and malignant intestinal epithelial cells. Strongly positive SK1 staining was found in 21/28 (75%) of rat colon adenocarcinomas induced by AOM, whereas no positive SK1 staining was observed in normal mucosa. The increase in SK1 and COX‐2 expression in AOM‐induced rat colon adenocarcinoma was confirmed at the level of mRNA by real‐time RT‐PCR. In addition, it was found that 1 ) down‐regulation of SK1 in HT‐29 human colon cancer cells by small interfering RNA (siRNA) decreases COX‐2 expression and PGE2 production; 2 ) overexpression of SK1 in RIE‐1 rat intestinal epithelial cells induces COX‐2 expression; and 3 ) S1P stimulates COX‐2 expression and PGE2 production in HT‐29 cells. These results suggest that the SK1/S1P pathway may play an important role in colon carcinogenesis, in part, by regulating COX‐2 expression and PGE 2 production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmed Cell Death Induced by Ceramide
Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993) · Science · doi:10.1126/science.8456305 · Cited by 1,794
Self-citation
Cited by
Sphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
“Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
Takabe, K., Paugh, S. W., Milstien, S., & Spiegel, S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07113 · Cited by 718
Role of ABCC1 in export of sphingosine-1-phosphate from mast cells
Mitra, P., Oskeritzian, C. A., Payne, S. G., Beaven, M. A., Milstien, S., & Spiegel, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603734103 · Cited by 407
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
Meyer zu Heringdorf, D., & Jakobs, K. H. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.026 · Cited by 388
Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
French, K. J., Zhuang, Y., Maines, L. W., Gao, P., Wang, W., Beljanski, V., Upson, J. J., Green, C. L., Keller, S. N., & Smith, C. D. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163444 · Cited by 317
Targeting SphK1 as a New Strategy against Cancer
Shida, D., Takabe, K., Kapitonov, D., Milstien, S., & Spiegel, S. (2008) · Current Drug Targets · doi:10.2174/138945008785132402 · Cited by 307
Ruckhäberle, E., Rody, A., Engels, K., Gaetje, R., von Minckwitz, G., Schiffmann, S., Grösch, S., Geisslinger, G., Holtrich, U., Karn, T., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9836-9 · Cited by 302
Role for sphingosine kinase 1 in colon carcinogenesis
Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y. A., & Obeid, L. M. (2009) · The FASEB Journal · doi:10.1096/fj.08-117572 · Cited by 280
Self-citationLysosomes as Oxidative Targets for Cancer Therapy
Dielschneider, R. F., Henson, E. S., & Gibson, S. B. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3749157 · Cited by 123
Metadata
- Authors
- Kawamori, T., Osta, W., Johnson, K. R., Pettus, B. J., Bielawski, J., Tanaka, T., Wargovich, M. J., Reddy, B. S., Hannun, Y. A., Obeid, L. M., & Zhou, D.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-11-30
- Volume
- 20
- Issue
- 2
- Pages
- 386-388
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2136584723
- Cited by
- 217
- References
- 1
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.